Drug details

Paclitaxel Tablets (paclitaxel)

type of Antineoplastics Antimicrotubular Taxanes

Paclitaxel Injection is a chemotherapy drug indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary. As first- line therapy, paclitaxel is indicated in combination with cisplatin. Paclitaxel injection is also indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy, for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy, and for the second-line treatment of AIDS-related Kaposi's sarcoma. Paclitaxel injection is available in generic form.

This drug may have the following side effects:
  • nausea,
  • vomiting,
  • diarrhea,
  • weakness,
  • infections,
  • swelling,
  • fainting, 
  • slow heart rate,
  • hair loss,
  • low white blood cell count (neutropenia),
  • feeling unwell (malaise), and
  • injection site reactions (including redness, tenderness, skin discoloration, or swelling)
The following drugs are related to Paclitaxel Tablets, either as a replacement or used together:
  • Aromasin (exemestane)
  • Ayvakit (avapritinib tablets)
  • Xeloda (capecitabine)
  • Cytoxan (cyclophosphamide)
  • Taxotere (docetaxel for injection)
  • Ellence (epirubicin hydrochloride)
  • Fareston (toremifene)
  • Faslodex (fulvestrant)
  • Femara (letrozole)
  • Gavreto (pralsetinib capsules)
  • Infugem (gemcitabine in sodium chloride injection)
  • Zoladex 3.6 (goserelin acetate implant)
  • Sancuso (granisetron transdermal system)
  • Herzuma (trastuzumab-pkrb for injection)
  • Zepzelca (lurbinectedin for injection)
  • Pemfexy (pemetrexed injection for intravenous use)
  • Soltamox (tamoxifen citrate)
The following supplements are related to Paclitaxel Tablets, and may be used together with the drug:
  • Melatonin (s.)
  • Adenosine (s.)
  • Coriolus Mushroom (s.)